Dolca Thomas ASDR Annual Scientific Meeting 2019

Dolca Thomas

Dolca Thomas is the Chief Medical Officer at Principia Biopharma. Prior to joining Principia, Dr. Thomas was Vice President and Global Head of Translational Medicine for Immunology, Inflammation, and Infectious Disease at Roche, where she was responsible for advancing multiple product candidates through clinical development. Prior to Roche, Dr. Thomas held roles of increasing responsibility at Pfizer, including Vice President of Clinical Development and Clinical Immunophenotyping, and Vice President and Chief Development Officer of the Biosimilars Research and Development Unit where she was responsible for all stages of development of multiple assets. Dr. Thomas began her industry career at Bristol-Myers Squibb as Director of Global Clinical Development in Immunology, where she was involved in the development and approval of belatacept. Dr. Thomas has been on faculty at Weill Cornell Medical-New York Presbyterian Hospital Department of Nephrology and Transplantation and at the St. Luke’s-Roosevelt Hospital Transplant Center in New York City. Dr. Thomas received her B.A. in sociology and her M.D. from Cornell University.

Abstracts this author is presenting: